Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lung Diseases, Interstitial: full-pipeline trial registry
6 of 11 indexed Lung Diseases, Interstitial trials are currently recruiting.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 6 currently recruiting · #1,577 of 28,707 conditions by registered trial count
Lung Diseases, Interstitial: 11 US clinical trials tracked, 6 recruiting.
Lung Diseases, Interstitial is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Boehringer Ingelheim, running 2 of these trials.
Enrollment posture brief
Registry condition lung-diseases-interstitial
OPEN 6 | RECR 55% | LATE 2 | EARLY 2 | RANK #1577 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Advanced Ovarian Carcinoma (55% recruiting · 11 trials)
Lung Diseases, Interstitial lists 6 open slots (55% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Lung Diseases, Interstitial on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Lung Diseases, Interstitial is recruiting above its size-band peers.
6 of 11 indexed trials (54.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Lung Diseases, Interstitial research.
Boehringer Ingelheim accounts for 2 of 11 trials (18.2%). 10 distinct sponsors appear on at least one study for this condition label.
-
Typical Lung Diseases, Interstitial enrolment sits around 70 participants.
Median target enrolment is 70 among the 11 trials that report a genuine target (sentinel values excluded). 6 of those (54.5%) plan for fewer than 100 participants.
-
Lung Diseases, Interstitial research is mostly interventional.
8 interventional and 3 observational studies make up this index (72.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
Dorothy P. and Richard P. Simmons Center for ILD Research Registry
University of Pittsburgh
NCT00258583
Cough Capture as a Portal Into the Lung
Albert Einstein College of Medicine
NCT05854563
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GlaxoSmithKline
NCT06572384
Physical Activity and Quality of Life in Fibrotic Lung Diseases After Initiating Anti-fibrotic Therapy and Pulmonary Rehabilitation
University of South Florida
NCT05866198
Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease
Maule Stem Cell Research Institute
NCT07372989
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
National Institute of Environmental Health Sciences (NIEHS)
NCT06325696
Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD
Third Pole Therapeutics
NCT05867914
Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease
Boehringer Ingelheim
NCT05957198
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)
University of Washington
NCT04281784
A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)
Boehringer Ingelheim
NCT04093024
Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest
Johns Hopkins University
NCT04170062
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Lung Diseases, Interstitial records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Lung Diseases, Interstitial trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Lung Diseases, Interstitial page
11 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Lung Diseases, Interstitial trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Boehringer Ingelheim sponsors the most Lung Diseases, Interstitial trials on record, review their full trial history before evaluating a specific study. See Boehringer Ingelheim's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lung Diseases, Interstitial condition card totals 11 registered trials; most-linked intervention EHR-based Clinician Jumpstart; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.